Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2024 / Nov / Real-Time Protein Imaging Sheds Light on Alzheimer’s Origins
Microscopy Clinical

Real-Time Protein Imaging Sheds Light on Alzheimer’s Origins

Atomic force microscopy captures real-time images of Alzheimer's-related amyloid protein aggregation, revealing “superspreader” fibrils that accelerate disease progression

11/08/2024 1 min read

Share

Suspicious protein molecules and fibrils aggregate on nerve cells in dementia.

Credit: Empa

Scientists have used advanced atomic force microscopy (AFM) to capture, for the first time, real-time, nanoscale images of amyloid-beta (Aβ-42) protein aggregates on fibrils, marking a significant step toward understanding the early mechanisms of Alzheimer’s disease progression. The study, led by Empa researcher Peter Nirmalraj and collaborators from the University of Limerick, tracked the formation of secondary nucleation sites on amyloid fibrils, where new aggregates form and potentially lead to cellular toxicity.

Aβ-42 proteins are known to misfold and clump into fibrils, forming dense structures that accumulate in the brain tissue of Alzheimer’s patients. Certain fibrils, termed “superspreaders,” were found to act as highly active nucleation sites, catalyzing further aggregation through surface features that bind new protein molecules. These superspreaders display rough, high-energy surfaces that facilitate continuous protein assembly, accelerating the formation of second-generation fibrils that may contribute to disease progression.

AFM, a high-resolution imaging technique, enabled the team to visualize these nanoscale interactions without the need for conventional staining. The researchers captured images of the fibrils in a salt solution, a medium that simulates the natural conditions of the human body. "This approach allowed us to observe the proteins in a state much closer to their native form," Nirmalraj noted in a press release. AFM provided important insights into the complex structure and activity of Aβ-42 fibrils, tracking their development over 250 hours and revealing how catalytic hotspots drive ongoing aggregation.

To validate the observations, the team paired AFM data with molecular model calculations, which supported the idea that specific surface textures enhance nucleation and the growth of aggregates. By classifying fibrils into subpopulations based on these surface characteristics, the researchers could distinguish between less active fibrils and those with a heightened potential for propagation.

The study helps reveal more about the underpinnings of Alzheimer’s pathology, highlighting the early aggregation sites as potential diagnostic and therapeutic targets.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.